TY - JOUR
T1 - Minimal important difference estimates for patient-reported outcomes
T2 - A systematic survey
AU - Carrasco-Labra, Alonso
AU - Devji, Tahira
AU - Qasim, Anila
AU - Phillips, Mark R
AU - Wang, Yuting
AU - Johnston, Bradley C
AU - Devasenapathy, Niveditha
AU - Zeraatkar, Dena
AU - Bhatt, Meha
AU - Jin, Xuejing
AU - Brignardello-Petersen, Romina
AU - Urquhart, Olivia
AU - Foroutan, Farid
AU - Schandelmaier, Stefan
AU - Pardo-Hernandez, Hector
AU - Hao, Qiukui
AU - Wong, Vanessa
AU - Ye, Zhikang
AU - Yao, Liam
AU - Vernooij, Robin W M
AU - Huang, Hsiaomin
AU - Zeng, Linan
AU - Rizwan, Yamna
AU - Siemieniuk, Reed
AU - Lytvyn, Lyubov
AU - Patrick, Donald L
AU - Ebrahim, Shanil
AU - Furukawa, Toshi A
AU - Nesrallah, Gihad
AU - Schünemann, Holger J
AU - Bhandari, Mohit
AU - Thabane, Lehana
AU - Guyatt, Gordon H
N1 - Funding Information:
Funding/support: This research was funded in part by the Canadian Institutes of Health Research (CIHR), Knowledge Synthesis grant number DC0190SR .
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2021/5
Y1 - 2021/5
N2 - OBJECTIVES: The objective of the study was to develop an inventory summarizing all anchor-based minimal important difference (MID) estimates for patient-reported outcome measures (PROMs) available in the medical literature.STUDY DESIGN AND SETTING: We searched MEDLINE, EMBASE, CINAHL, PsycINFO, and the Patient-Reported Outcome and Quality of Life Instruments Database internal library (January 1989-October 2018). We included primary studies empirically calculating an anchor-based MID estimate for any PROM in adults and adolescents. Pairs of reviewers independently screened and selected studies, extracted data, and evaluated the credibility of the MIDs.RESULTS: We identified 585 eligible studies, the majority conducted in Europe (n = 211) and North America (n = 179), reporting 5,324 MID estimates for 526 distinct PROMs. Investigators conducted their studies in the context of patients receiving surgical (n = 105, 18%), pharmacological (n = 85, 15%), rehabilitation (n = 65, 11%), or a combination of interventions (n = 194, 33%). Of all MID estimates, 59% (n = 3,131) used a global rating of change anchor. Major credibility limitations included weak correlation (n = 1,246, 23%) or no information regarding the correlation (n = 3,498, 66%) between the PROM and anchor and imprecision in the MID estimate (n = 2,513, 47%).CONCLUSION: A large number of MIDs for assisting in the interpretation of PROMs exist. The MID inventory will facilitate the use of MID estimates to inform the interpretation of the magnitude of treatment effects in clinical research and guideline development.
AB - OBJECTIVES: The objective of the study was to develop an inventory summarizing all anchor-based minimal important difference (MID) estimates for patient-reported outcome measures (PROMs) available in the medical literature.STUDY DESIGN AND SETTING: We searched MEDLINE, EMBASE, CINAHL, PsycINFO, and the Patient-Reported Outcome and Quality of Life Instruments Database internal library (January 1989-October 2018). We included primary studies empirically calculating an anchor-based MID estimate for any PROM in adults and adolescents. Pairs of reviewers independently screened and selected studies, extracted data, and evaluated the credibility of the MIDs.RESULTS: We identified 585 eligible studies, the majority conducted in Europe (n = 211) and North America (n = 179), reporting 5,324 MID estimates for 526 distinct PROMs. Investigators conducted their studies in the context of patients receiving surgical (n = 105, 18%), pharmacological (n = 85, 15%), rehabilitation (n = 65, 11%), or a combination of interventions (n = 194, 33%). Of all MID estimates, 59% (n = 3,131) used a global rating of change anchor. Major credibility limitations included weak correlation (n = 1,246, 23%) or no information regarding the correlation (n = 3,498, 66%) between the PROM and anchor and imprecision in the MID estimate (n = 2,513, 47%).CONCLUSION: A large number of MIDs for assisting in the interpretation of PROMs exist. The MID inventory will facilitate the use of MID estimates to inform the interpretation of the magnitude of treatment effects in clinical research and guideline development.
KW - Adolescent
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Child
KW - Drug Therapy/statistics & numerical data
KW - Europe
KW - Female
KW - Humans
KW - Male
KW - Middle Aged
KW - North America
KW - Observer Variation
KW - Patient Reported Outcome Measures
KW - Patient Satisfaction/statistics & numerical data
KW - Rehabilitation/statistics & numerical data
KW - Surgical Procedures, Operative/statistics & numerical data
KW - Young Adult
KW - Patient-reported outcome measure
KW - Minimal important difference
UR - http://www.scopus.com/inward/record.url?scp=85100062202&partnerID=8YFLogxK
U2 - 10.1016/j.jclinepi.2020.11.024
DO - 10.1016/j.jclinepi.2020.11.024
M3 - Review article
C2 - 33321175
SN - 0895-4356
VL - 133
SP - 61
EP - 71
JO - Journal of Clinical Epidemiology
JF - Journal of Clinical Epidemiology
ER -